J.V. DeGiovanni Birmingham Children’s Hospital & University Hospital Birmingham UK Advanced Angioplasty 2007 Ventricular Septal Defects Transcatheter Closure.

Slides:



Advertisements
Similar presentations
TOF with Absent Pulmonary Valve
Advertisements

VENTRICULAR SEPTAL DEFECT (VSD)
Atrioventricular Canal Defect
Congenital Heart Defects Fred Hill, MA, RRT. Categories of Heart Defects Left-to-right shunt Cyanotic heart defects Obstructive heart defects.
Disclosure Information Devices for ASD&PFO Closure: Amplatzer Devices As a faculty member for this program, I disclose the following relationships with.
Update of Transcatheter Closure of Ventricular Septal Defect in China Yong-wen Qin Department of Cardiology, Changhai Hospital, Second Military Medical.
Acyanotic Congenital Heart Disease
Indications for intervention of ASD and VSD
Jonas D. Del Rosario, MD, FPCC Clinical Associate Professor UP College of Medicine.
Ebstein’s Malformation
Post-infarction Ventricular Septal Rupture and Free Wall Rupture 서울삼성병원 성균관대학교 김욱성.
Early management of congenital heart diseases Jameel A. AL-Ata Consultant & assistant professor of pediatrics & pediatric cardiology.
Boston Children’s Hospital, Harvard Medical School
Atrial Septal Defect Dr. mahsa ghasemi.
Atrial Septal Defect Closure
Current Status and Prospect of Interventional Congenital Heart Disease
Ventricular Septal Defects
Cardiac Case 9/15/07. Coarctation of the Aorta Congenital narrowing of the thoracic aorta; typically distal to the left subclavian artery. M:F – 2:1.
Transhepatic venous cardiac catheterization
Congenital heart disease
A shifting paradigm of care: Advances in transcatheter heart valve procedures Sandra Lauck MSN, RN, CCN(C) Clinical Nurse Specialist, Arrhythmia Management.
KING ABDULAZIZ UNIVERSITY HOSPITAL CARDIAC SURGERY UNIT Dr. Khalid Al-Ibrahim Dr. Hussein Jabbad Dr. Khalid Medhat Dr. Ragab Shehata.
The Atrioventricular Block in pediatric cardiology Coordinator: Dr. GOZAR LILIANA Author: BENTZ OANA.
Department of Cardiolog Shenyang Northern Hospital
How I would do my anterior VSD Closure
Department of CTVS.  56 years old male from Cuttack  Date of admission  Date of surgery  Date of death  Diagnosis:
Cardiothoracic Surgery. Topics Valvotomy and valve replacement Open heart surgery and cardiac bypass surgery Correction of congenital heart diseases Heart.
NURSING CARE OF THE CHILD WITH A CARDIOVASCULAR DISEASE Clinical Aspect of Maternal and Child Nursing NUR 363 Lecture 9.
Ventricular Septal Defect & Aortic Incompetence Seoul National University Hospital Department of Thoracic & Cardiovascular Surgery.
AORTIC-LEFT VENTRICULAR TUNNEL. BASICS –CONNECTION BETWEEN AORTA AND LV, NOT INVOLVING THE AORTIC VALVE –USUALLY ARISE FROM R CORONARY SINUS, MOST COMMONLY.
Percutaneous Establishment of Tricuspid Regurgitation: An Experimental Model for Transcatheter Tricuspid Valve Replacement Yuan Bai, Gang-jun Zong, Yong-wen.
Clinical Review AbioCor® Implantable Replacement Heart H Julie Swain M.D. Cardiovascular Surgeon Ileana Piña M.D. Heart Failure Cardiologist DRAFT.
Closure of ventricular septal defect,continous versus conventional closure, comparative study.
One-stage repair for Stanford Type B Aortic Dissection concomitant with cardiac diseases Open stented elephant trunk technique combined with cardiac operation.
Ventricular Septal Defect in adults
Surgically-BasedDevice VSD Closure Olaf Wendler Department of Cardiothoracic Surgery King‘s College Hospital.
Ventricular septal defects
Intervention of Aortic Coarctation: from Angioplasty to Stent
Basic Echocardiography Additional Information Wendy Blount, DVM Nacogdoches TX Wendy Blount, DVM Nacogdoches TX.
By M.elkhatib.  Equal  R = L  Q refers to flow  Therefore Qp = Qs  Blood flow to both the pulmonary & systemic circulations is balanced.  Homeostasis.
Adult with operated congenital heart disease: what should we check for? January 15 th, h-17h30.
Infective Endocarditis
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pediatric Cardiac Interventions J Am Coll Cardiol.
Pacemaker following adult cardiac surgery DR M HASANZADEH MUMS NOV 2014.
H. Amoozgar, MD Professor of pediatric cardiology Shiraz University of Medical Sciences, Shiraz, Iran TRANSCATHETER CLOSURE OF LARGE CORONARY-CAMERAL FISTULAE.
Causes of Heart Valve Dysfunction Congenital defects (bicuspid aortic valve) Infections (rheumatic fever and bacterial endocarditis Coronary artery disease.
EXPANDING INDICATIONS OF TRANSCATHETER HEART VALVE INTERVENTIONS. JACC CARDIOVASCULAR INTERVENTION. DR.RAJAT GANDHI.
VSD post TAVR: Mechanisms, Presentation and Management
Complex ASD Closures John M
Cardiovascular system
PERCUTANEOUS PULMONARY VALVE REPLACEMENT:
Challenging Case Presentation For Structural Heart Disease Program
New AGA Devices PDA II, Vascular Plug IV, Membranous VSD and and Left Atrial Appendage Occluder Dr. John M. Lasala MD PhD Director Interventional Cardiology.
Percutaneous Closure of a Coronary Fistula
CONGENITAL HEART DISEASES II
One-stop Hybrid Cardiac Surgery
Transcatheter closure of postinfarction ventricular septal rupture
Cardiac Cath NUR 422.
Nat. Rev. Cardiol. doi: /nrcardio
Operative Techniques for Repair of Muscular Ventricular Septal Defects
Minimally invasive transthoracic device closure of isolated ventricular septal defects without cardiopulmonary bypass: Long-term follow-up results  Quansheng.
Transcatheter closure of postinfarction ventricular septal rupture
Alternative method of patch implantation and creation for postinfarction ventricular septal defect repair by the infarct exclusion technique  Masashi.
B. Zane Atkins, MD, Zubair A. Hashmi, MD, Asvin M. Ganapathi, MD, J
Transcatheter Closure of Congenital Perimembranous Ventricular Septal Defect in Children Using Symmetric Occluders: An 8-Year Multiinstitutional Experience 
Syed T. Hussain, MD, Kwabena Mawulawde, MD, Samir R
Karim A. Diab, MD, Ziyad M. Hijazi, MD, Qi-Ling Cao, MD, Emile A
Timing for successful surgical management of heart block after placement of an Amplatzer occlusion device for secundum atrial septal defect repair  Umang.
Impact of Intraoperative Transesophageal Echocardiography on Surgical Decisions in 12,566 Patients Undergoing Cardiac Surgery  Holger K. Eltzschig, MD,
Young-Sang Sohn, MD, Christian P
Presentation transcript:

J.V. DeGiovanni Birmingham Children’s Hospital & University Hospital Birmingham UK Advanced Angioplasty 2007 Ventricular Septal Defects Transcatheter Closure

MY CONFLICTS OF INTEREST ARE: Consultant for AGA Medical Corporation Proctor and lecturer for AGA Medical, NMT Medical, WL Gore Steering Committee member for Helex (Gore), SolySafe (Carag), BioStar (NMT)

Study Details September 2001 – January 2007 September 2001 – January 2007 Total number VSD devices : 160 Total number VSD devices : 160 Muscular Devices: 59 Muscular Devices: 59 Perimembranous Devices: 43 Perimembranous Devices: 43 Post-infarct: 43 Post-infarct: 43 Post-trauma: 3 Post-trauma: 3 Residual post-surgery 12 Residual post-surgery 12

VSD Types Congenital:Perimembranous, Muscular, Gerbode, Doubly-committed Congenital:Perimembranous, Muscular, Gerbode, Doubly-committed Acquired:Iatrogenic Acquired:Iatrogenic Residual post-surgery Post-traumaPost-infarct

Indications Left ventricular volume overload Left ventricular volume overload Heart failure/Cardiogenic shock Heart failure/Cardiogenic shock Aortic regurgitation Aortic regurgitation Haemolysis Haemolysis History of endocarditis History of endocarditis Career reasons Career reasons Achieving normality (?) Achieving normality (?)

Technique General Anaesthesia General Anaesthesia Trans-oesophageal echocardiography Trans-oesophageal echocardiography Femoral vein/femoral artery Femoral vein/femoral artery Internal jugular vein/femoral artery Internal jugular vein/femoral artery Angiography Angiography +/- Balloon sizing (post-MI only) +/- Balloon sizing (post-MI only) Amplatzer device placement and release Amplatzer device placement and release Heparin, antibiotics, antiplatelets Heparin, antibiotics, antiplatelets Associated procedures (ASD, BAV, RFA, VSD coil, Pulm Valvuloplasty) Associated procedures (ASD, BAV, RFA, VSD coil, Pulm Valvuloplasty)

Amplatzer Muscular Devices MuscularWaist diameter 4 – 18 mm MuscularWaist diameter 4 – 18 mm Waist length 7 mm Sheath size 6 – 8 Fr Muscular PIWaist diameter Muscular PIWaist diameter Waist length 10 mm Sheath size 9 – 10 Fr Left disc rim 4 mm, right disc 3mm, size increments 2 mm

Muscular VSDs Inlet Inlet Muscular/Apical Muscular/Apical Outlet Outlet

Muscular Inlet

Mid-Muscular

Muscular Outlet

Multiple VSDs

Horse Kick, surgery, 3 devices, alive Horse Kick, surgery, 3 devices, alive Bike accident, device closure, alive Bike accident, device closure, alive Car accident, device pulled through, surgery, died Car accident, device pulled through, surgery, died Post-trauma n = 3

Pt No = 38; Procedures = 43 Pt No = 38; Procedures = 43 Male/Female = 22/16 Male/Female = 22/16 Age Range(Mean) = 52 – 81 (68.6 yrs) Age Range(Mean) = 52 – 81 (68.6 yrs) Acute/Chronic (First device) = 29/9 Acute/Chronic (First device) = 29/9 Acute/Chronic (Second device) = 3/2 Acute/Chronic (Second device) = 3/2 Mean Interval between MI and Closure 129 days Mean Interval between MI and Closure 129 days Ditto for second device 201 days Ditto for second device 201 days Earliest device 2 days, longest 5.3 yrs Earliest device 2 days, longest 5.3 yrs Mean Follow-up 18.8 months Mean Follow-up 18.8 months Post-infarct VSD Patient Details -- ALL

Apical18 Apical18 Anterior6 Anterior6 Muscular5 Muscular5 Inlet/Inferior9 Inlet/Inferior9 Septal aneurysm6 Septal aneurysm6 Multiple5 Multiple5 No of defects (No of Pts) 2(2), 3(1), 4(1) VSD Site

FA/Jugular30 FA/Jugular30 FA/FV 12 FA/FV 12 Brachial A/Jugular 1 Brachial A/Jugular 1 Procedure Time55 – 300 (153) Mins Procedure Time55 – 300 (153) Mins Fluoro Time13.6 – 133 (39) Mins Fluoro Time13.6 – 133 (39) Mins Device size8 – 24 (18.7) Device size8 – 24 (18.7) Approach

Planning & Preparation Maximize fluids and inotropes Maximize fluids and inotropes IABP but shoot coronaries and consider vital stenting IABP but shoot coronaries and consider vital stenting Allow recovery from reperfusion injury Allow recovery from reperfusion injury Early intervention is usually best Early intervention is usually best Minimize procedural time and trauma Minimize procedural time and trauma Surgical back-up Surgical back-up Post-Op care Post-Op care Possible hybrid in some cases Possible hybrid in some cases

Aortic Pressure Black = Baseline Red = With Balloon

Courtesy Dr John Davis

Courtesy Dr Huon Gray

Major complications Leg gangrene1 Leg gangrene1 Contra leg embolus1 Contra leg embolus1 IABP sepsis1 IABP sepsis1 Inadequate post-op care1 Inadequate post-op care1 Device embolisation2 Device embolisation2 TV damage (repaired)1 TV damage (repaired)1 No endothelialisation (surgery)1 No endothelialisation (surgery)1 Pericardial effusion2 Pericardial effusion2 Failure (VSD too large)2 Failure (VSD too large)2 Death 12 Death 12 (All=31.5%, Cardiac 26.3%, Ideal 15.7%) (All=31.5%, Cardiac 26.3%, Ideal 15.7%)

Conclusion Transcatheter closure of VSDs in various locations can be safely and effectively carried out using the Amplatzer occluders Transcatheter closure of VSDs in various locations can be safely and effectively carried out using the Amplatzer occluders Results are encouraging. Muscular defects comparable to surgery; perimembranous marginally less good than surgery. Post-infarct still carry high risk but better results than surgery Results are encouraging. Muscular defects comparable to surgery; perimembranous marginally less good than surgery. Post-infarct still carry high risk but better results than surgery Long term follow-up essential Long term follow-up essential Design changes likely to follow Design changes likely to follow Acknowledgment Acknowledgment

Acknowledgement Been M, Clift P,Davis J, Flapan D, Gray H, Hildick Smith D, Jenkins J, Khogali S, Ludman P, Northridge D, Thorne S, Townend J, Turner M, Walker M,Wheeldon N Been M, Clift P,Davis J, Flapan D, Gray H, Hildick Smith D, Jenkins J, Khogali S, Ludman P, Northridge D, Thorne S, Townend J, Turner M, Walker M,Wheeldon N

Perimembranous n = 42 Simple Simple With aneurysm:Single exit With aneurysm:Single exit Multiple exits Windsock in RVOT Aortic valve prolapse Aortic valve prolapse

Muscular Device n = 70 Congenital Muscular VSD22 Congenital Muscular VSD22 Congenital Perimembranous VSD36 Congenital Perimembranous VSD36 Post-surgery residual 9 Post-surgery residual 9 Post-trauma 3 Post-trauma 3 Associated procedures: P. Valvuloplasty(1), PA band dilatation (1) Associated procedures: P. Valvuloplasty(1), PA band dilatation (1)

TGA, Switch, Absent IVC, VSD

Muscular Outlet

Ebstein LV to RA

Perimemb/Musc Devices Failed in 4:VSD too large (Post-trauma) Failed in 4:VSD too large (Post-trauma) Device caused LVOTO Post-Fallot 3 rd Op. VSD too big Transient AV block with sheath No conduction problems apart from 3 with LAHB, normal PR No conduction problems apart from 3 with LAHB, normal PR No TR, AI, clots, infection No TR, AI, clots, infection Device embolisation in 2 with PMVSD.Retrieved & replaced Device embolisation in 2 with PMVSD.Retrieved & replaced Device removed severe haemolysis + large shunt Device removed severe haemolysis + large shunt Transient mild haemolysis in 2 (Resolved) Transient mild haemolysis in 2 (Resolved) No deaths No deaths Small residual shunt in 6 Small residual shunt in 6

Off Label Usage of Amplatzer Muscular Occluder Membranous VSD with aneurysm Membranous VSD with aneurysm Huge PDAs Huge PDAs Large AV malformations Large AV malformations Paravalvar prosthetic leaks Paravalvar prosthetic leaks

Iatrogenic

Residual Post-Op